IFITM2 and amyotrophic lateral sclerosis: Neu_c4_RSAD2, Isg15_Neu, IFITM2_Neu, CCL6_Neu, and Cd34_mNeu were assessed as specific panels (OER10 > 83%, data was not shown) in anti-NMDA receiver encephalitis, which was significantly different from that of amyotrophic lateral sclerosis.